secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hoth Therapeutics, Inc. (HOTH)
CIK:        0001711786
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001213900-22-068985
Event type: other_material
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 3.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hoth Therapeutics issues 2M shares of Series B Preferred with 10-to-1 voting for $1,000
--------------------------------------------------------------------------------

- Sold 2,000,000 Series B Preferred shares to a single investor for aggregate $1,000; shares have $0.0001 par value.
- Each Series B share carries 10 votes, voting only on Authorized Stock Increase; no dividend or liquidation rights.
- Series B Preferred automatically redeemed for $10 upon effectiveness of Authorized Stock Increase or at board's discretion.
- Shares issued in unregistered transaction relying on Section 4(a)(2) exemption.
- Certificate of Designation filed in Nevada to create the new series.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022068985/0001213900-22-068985-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1711786/000121390022068985/ea167990-8k_hoththera.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-068985

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer